Cologne, Germany

Mathias Gehrmann

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Myriad International Gmbh, Siemens Healthcare Diagnostics Gmbh, Sividon Diagnostics Gmbh. Active years: 2006-2024.

USPTO Granted Patents = 7 

% Patents Active = 85.7


 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Tönisvorst, DE (2009)
  • Leverkusen, DE (2006 - 2010)
  • Cologne, DE (2019 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Mathias Gehrmann: Pioneering Inventor from Cologne

Introduction: Mathias Gehrmann is a renowned inventor hailing from Cologne, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Mathias Gehrmann holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Mathias Gehrmann has worked with leading research institutions and technology companies, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Mathias Gehrmann has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects. His collaborative efforts have led to the development of cutting-edge technologies that have received international acclaim.

Conclusion: Mathias Gehrmann's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global tech community. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…